As the first study to elucidate the extensive relationship between TIGD1 and pan-cancer, these findings suggest that TIGD1 may function as an oncogene and serve as a valuable biomarker in cancer diagnostics, therapeutics, and immunotherapy strategies. Here, TIGD1 is linked to cancer.